Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- 46%
- Liquidez
- $27.84K
- Mejor compra
- 1%
- Mejor venta
- 99%
- Spread
- 98%
- Ultimo trade
- 46%
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- 1%
- Mejor venta
- 99%
- Punto medio
- 50%
- Spread
- 98%
- Ultimo trade
- 46%
- Profundidad
- 438,49 / 27.398,1
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|---|
| 1% | 20.11 |
| 2% | 5.39 |
| 5% | 10 |
| 6% | 10 |
| 7% | 300 |
| 8% | 67.94 |
| 42% | 23.8 |
| 46% | 1.25 |
Ventas
| Precio | Tamano |
|---|---|
| 99% | 18.005,06 |
| 98% | 7,28 |
| 95% | 300 |
| 94% | 5581 |
| 93% | 6,99 |
| 92% | 26,27 |
| 89% | 600 |
| 80% | 1350 |
Trades
Trades recientes
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 54% 23.74 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 51.5% 597.8 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 20 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?Yes 49% 12 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 0.48 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 43 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 30.36 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 52.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 50% 19 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 18.9% 52.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 5% 43 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?No 11% 20 shares